prof. MUDr. Michael Doubek, Ph.D.
Head of the research group, Michael Doubek Research Group: Genetic predisposition to hematologic disorders Neuroscience
correspondence Address:
Jihlavská 340/20, 625 00 Brno
phone: | +420 532 23 2144, 3603 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 871
2024
-
A novel thrombocytopenia-4-causing CYCS gene variant decreases caspase activity: Three-generation study
British journal of haematology, year: 2024, DOI
-
FoxO1/Rictor axis induces a non-genetic adaptation to Ibrutinib via Akt activation in chronic lymphocytic leukemia
The Journal of Clinical Investigation, year: 2024, DOI
-
Gamma-delta T cells in newly diagnosed patients with chronic lymphocytic leukaemia
Year: 2024, type:
-
Impact of thrombocytopenia-associated c.-118C>T and c.-140C>G ANKRD26 5’UTR variants in three-generational pedigree
Platelets, year: 2024, volume: 35, edition: 1, DOI
-
Innate effector gamma-delta T cells in newly diagnosed patients with chronic lymphocytic leukaemia
Year: 2024, type: Appeared in Conference without Proceedings
-
Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients
British journal of haematology, year: 2024, volume: 204, edition: 1, DOI
-
Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study
Hematological Oncology, year: 2024, volume: 42, edition: 3, DOI
-
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM
Blood advances, year: 2024, volume: 8, edition: 11, DOI
-
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drug
Leukemia, year: 2024, volume: 38, edition: 8, DOI
-
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL
HemaSphere, year: 2024, volume: 8, edition: 9, DOI